z-logo
Premium
In Vivo X‐ray Triggered Catalysis of H 2 Generation for Cancer Synergistic Gas Radiotherapy
Author(s) -
Wu Ying,
Su Lichao,
Yuan Meng,
Chen Tao,
Ye Jiamin,
Jiang Yifan,
Song Jibin,
Yang Huanghao
Publication year - 2021
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.202100002
Subject(s) - radiation therapy , in vivo , materials science , cancer , photocatalysis , amorphous solid , cancer research , x ray , nanotechnology , catalysis , chemistry , medicine , crystallography , biochemistry , optics , biology , microbiology and biotechnology , physics
To date, hydrogen (H 2 ) therapy has received widespread attention. However, X‐ray triggered sustainable H 2 ‐producing materials with controlled release for cancer treatment have not been reported. Herein, an X‐ray triggered sustainable in situ H 2 producing platform, Au NR‐TiO 2 @ZnS:Cu,Co‐A(Au‐TiO 2 @ZnS), composed of Au‐amorphous TiO 2 nano‐dumbbell‐shaped heterostructure coated with long afterglow particles, was developed for cancer synergistic H 2 ‐radiotherapy. The mechanism of H 2 production was verified by theoretical calculations and in vitro experiments. Changes in the apoptosis pathway caused by the synergistic effect of H 2 and radiotherapy were reported. Guided by its excellent photoacoustic imaging capabilities, mice with orthotopic liver cancer achieved excellent therapeutic effects and low inflammatory side effects, suggesting that Au‐TiO 2 @ZnS has promising application potential for cancer treatment and prognosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom